JM is an investigative writer and strategic thinker, renowned for being inquisitive and persistent. He’s been intensively trained to maintain a cool, level-headed and analytical focus under extreme conditions. With close to 10 years of supreme low flying in the Canadian and Dutch Air Forces, JM has managed risk in the most demanding of circumstances; experience which he’s put to good use following his decision to set his sights on a career in highly focused asset management.
After settling down on Wall Street, JM received his Series 7 and Series 9/10 securities license, and specialised in equity & derivatives trading. He has experienced all financial crashes and crises of the 80’s, 90’s and 2000’s at close quarters, and for >38 years lived and breathed the investment management & venture capital I ndustry.
During the 90’s and 2000’s, JM further specialised in the healthcare & biotechnology industries. His strength is detection of major trends and shifts in drug development and macro-economic events. He’s recognised for broad scientific insight and in-depth knowledge about financial markets.
In June 2000, JM set up and ran a deep-focus private equity firm with a close friend and business partner. They operated with two high quality advisory boards and established a strong, international network. In 2011, they sold the company and up until December 2019, managed a buy-out of the firm’s main asset. JM’s 25-year track record shows a consistent 30% annual return.
The Key to Success.
—————————Disclaimer: BlogChain is about investigative journalism and strictly not about recommendations to trade securities, currencies/crypto’s and/or derivatives. It’s about narratives meant to provide foresight into the discreet world of finance. Action in reliance upon the info is at your own risk.